Company Filing History:
1 out of 1 
1 out of 832,912 Years Active: 2023-2026
Title: Olga Vladimirovna Britanova: Innovator in Monoclonal Antibodies
Introduction
Olga Vladimirovna Britanova is a prominent inventor based in Moscow, Russia. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 4 patents to her name, her work focuses on innovative treatments for diseases associated with the human T cell receptor family.
Latest Patents
Her latest patents include groundbreaking inventions such as monoclonal antibodies that specifically bind to human TRBV9. This invention encompasses a humanized antibody or antigen-binding fragment that targets the TRBV9 family of the human T cell receptor. Additionally, she has developed a nucleic acid encoding the antibody, an expression vector, and methods for preparing the antibody. These innovations are aimed at treating diseases or disorders linked to the human T cell receptor family, including ankylosing spondylitis, celiac disease, and malignant blood diseases.
Another notable patent involves monoclonal antibodies against the beta chain region of human TRBV9. This invention also includes a humanized antibody or antigen-binding fragment that specifically binds to the TRBV9 family. The associated nucleic acid, expression vector, and preparation methods further enhance the potential for therapeutic applications in treating various diseases.
Career Highlights
Olga's career is marked by her dedication to advancing medical science through her innovative research. Her work has the potential to significantly impact the treatment of autoimmune diseases and cancers, showcasing her commitment to improving patient outcomes.
Collaborations
Throughout her career, Olga has collaborated with esteemed colleagues such as Sergey Anatolievich Lukyanov and Dmitry Borisovich Staroverov. These partnerships have fostered a collaborative environment that enhances the development of her groundbreaking inventions.
Conclusion
Olga Vladimirovna Britanova stands out as a leading inventor in the field of monoclonal antibodies, with her innovative patents paving the way for new treatments for serious health conditions. Her contributions to biotechnology reflect her commitment to advancing medical science and improving lives.